Where do you begin with Monoclonal Antibodies? Can existing techniques be adapted for a cost- and time-efficient solution?
Are these the questions you face today? Would hearing the strategies being explored by the leading researchers and pharmaceutical companies help you to advance through processing methods more efficiently? If the answer is yes, then you need to look at the World Monoclonal Antibody Congress 2013, which is taking place on 19- 20 March in London, UK.
The objective of this conference is to provide communication, education and networking opportunities for scientists engaged in Monoclonal Antibodies whether in academia, biotech or industry.Attendees will hear world-class speakers discussing the challenges and opportunities facing the Monoclonal Antibodies field.
Our Monoclonal Antibodies Conference will encompass six scientific areas:
Identify suitable assays for evaluating the immunogenicity of MAbs
Recent advances in antibody engineering and modification technologies
Monoclonal antibody purification techniques and future developments
Antibody-based targeted therapy
Commercial opportunities & strategies to develop Monoclonal Antibodies
Investment & potential returns from Monoclonal Antibodies
For more information visit the website: www.appelconsulting.co.uk/events.php?prop_id=182
Dr. Tim Hiddemann
Managing Director, Co-Founder
"Discover our huge product range which comes along with a smooth purchasing process."